The orthogonal system of regulating translation: the AegiSafe O-Key

The synthesis of protein relies on the transcription-translation network. In transcription, mRNA is synthesized through complementary base pairing by RNA polymerase from the DNA template, and is followed by translation. Translation is the third stage of protein biosynthesis. In translation, mRNA produced by transcription is decoded by the ribosome to produce a specific amino acid chain, or polypeptide, that will later fold into an active protein. Therefore, we can say that translation is one of most important of activities in a cell.

Due to its importance of protein synthesis, there are intricate and delicate regulation systems. To regulate transcription, cells alter the gene expression levels. This is called transcriptional regulation. Many means of transcriptional regulation, such as various mechanisms as specificity factors, activators, etc., are presented in a cell. There are also inducible and repressible systems, and transcription factor that can determine the initiation rate of transcription.

While a number of genetic tools exist for regulating transcription in cells, far fewer tools exist for translation. Of the tools available in bacteria, the most popular are riboregulators, both cis- and trans-activating, and orthogonal ribosomes (o-ribosomes). In terms of reprograming translation, o-ribosomes are especially powerful as they enable one to partially decouple translation from the native protein synthesis machinery. In particular, o-ribosomes can translate genes with altered Shine-Dalgarno (SD) sequences not recognized by host ribosomes. Therefore, o-ribosomes can be used to explore gene expression dynamics as they potentially provide a method for tuning translation rates. Furthermore, o-ribosomes may have application in synthetic biology as they introduce new functionality within cells.

In this year's project, we focus on modifying the Sine-Dalgarno (SD) sequence of the mRNA and the anti-Shine-Dalgarno (ASD) sequence of the 16S rRNA of the ribosome to construct an orthogonal translation system called the AegiSafe O-Key. Aegis was originally the shield that was associated with Zeus and Athena, which offers protection. AegiSafe means our orthogonal system secure the environment from potential biosafety issue. O-Key stands for orthogonal system that includes orthogonal ribosome (o-ribosome, O-Key) and orthogonal RBS (o-RBS, O-Lock), which indicates that our system can not only shut down contamination, but also using the orthogonal system to selectively open our translation pathway like a key to a lcok. This is a truly amazing system for two independent translation systems co-existing harmoniously and working effectively in one single cell. In the following sections, we will elaborate on the AegiSafe O-Key about the orthogonal system and its application.

The Overview of Orthogonal Ribosome (O-Key)

Ribosome

Ribosome is the protein factory of a cell, an organelle without membrane. Its sophisticated structure guarantees the accurate information flow from mRNA to protein. Ribosomes consist of two subunits that fit together and work as one to translate the mRNA into a polypeptide chain during protein synthesis.

Prokaryotes have 70S ribosomes, each consisting of a small (30S) and a large (50S) subunit. The smaller subunit binds to the mRNA pattern, while the larger subunit binds to the tRNA and the amino acids. Their small subunit has a 16S RNA subunit (consisting of 1540 nucleotides) bound to 21 proteins. The large subunit is composed of a 5S RNA subunit (120 nucleotides), a 23S RNA subunit (2900 nucleotides) and 31 proteins. Crystallographic work has shown that there are no ribosomal proteins close to the reaction site for polypeptide synthesis. This suggests that the protein components of ribosomes act as a scaffold that may enhance the ability of rRNA to synthesize protein rather than directly participating in catalysis, while the rRNA reacts with the mRNA and catalyze the synthesis.

In bacterial cells, ribosomes are synthesized in the cytoplasm through the transcription of multiple ribosome gene operons.

The rRNAs that make up the ribosome are directly translated from the rRNA operon rrnB. The three E. coli rRNA molecules – 23S, 16S, and 5S – are derived from a single 30S rRNA precursor transcript that also includes several tRNAs.

16s ribosome RNA

16S ribosomal RNA (or 16S rRNA) is a component of the 30S small subunit of prokaryotic ribosomes. It is approximately 1.5kb (or 1500 nucleotides) in length. The genes coding for it are referred to as 16S rDNA and are used in reconstructing phylogenies.

Multiple sequences of 16S rRNA can exist within a single bacterium. It has several functions:

• Like the large (23S) ribosomal RNA, it has a structural role, acting as a scaffold defining the positions of the rebosomal proteins.
• The 3' end contains the anti-Shine-Dalgarno sequence, which binds upstream to the AUG start codon on the mRNA. The 3'-end of 16S RNA binds to the proteins S1 and S21 known to be involved in initiation of protein synthesis; RNA-protein cross-linking by A.P. Czernilofsky et al. (FEBS Lett. Vol 58, pp 281–284, 1975).
• Interacts with 23S, aiding in the binding of the two ribosomal subunits (50S+30S)
• Stabilizes correct codon-anticodon pairing in the A site, via a hydrogen bond formation between the N1 atom of Adenine (see image of Purine chemical structure) residues 1492 and 1493 and the 2'OH group of the mRNA backbone.

For the 16s of them has a structural role, acting as a scaffold defining the positions of the ribosomal proteins. The 3' end contains the anti-Shine-Dalgarno sequence, which binds upstream to the UG start codon on the mRNA. We note that the complementary position and length can have big impact on the translational result of back gene. This feature stimulates our thinking about the blueprint of our project. That is to reform some part of 16s to create our experiment result. WE do some exact test according to the paper, at last we choose this sequence to change to make our project come true.

Orthogonal (Aegisafe) Gibson Free Energy

Orthogonal Ribosome (O-Key)

Gene expression involves two steps, transcription and translation. While a number of genetic tools exist for reprograming transcription in cells, far fewer tools exist for translation. Of the tools available in bacteria, the most popular are riboregulators, both cis- and trans- activating, and Aegisafe O-key (orthogonal ribosome), also known as specialized ribosomes. In terms of reprograming translation, O-key are especially powerful as they enable one to partially decouple translation from the native protein synthesis machinery. In particular, O-key can translate genes with altered Shine-Dalgarno (SD) sequences not recognized by host ribosomes. Because of the fact, O-key can be used to explore translational regulatory mechanisms such as coupling and to probe ribosome structure. Furthermore, O-key can be used to explore gene expression dynamics as they potentially provide a method for tuning translation rates. Finally, O-key may have application in synthetic biology as they introduce new functionality within cells. O-key are duplicated ribosomes with mutations in the 3' end of 16s rRNA that alter their specificity for mRNA. In bacteria, translation initiation is primarily mediated by interactions between the 30s ribosomal subunit during the initiation process. The strength of this interaction is thought to influence translational efficiency as mutations in either the SD or ASD sequence that weaken the interaction reduce the amount of protein made. In the case of O-key, mutations are introduced into the ASD region such that they can based pair with complementary noncanonical SD sequences not recognized by host ribosomes.

Gibson Free Energy

ΔG_tot=ΔG_mRNA:rRNA+ΔG_start+ΔG_spacing-ΔG_standby-ΔG_mRNA

ΔG_mRNA:rRNA is the energy released when the last nine nucleotides(nt) of the E. coli 16S rRNA (3′-AUUCCUCCA-5′) hybridizes and co-folds to the mRNA sub-sequence (ΔG_mRNA:rRNA<0). Intramolecular folding within the mRNA is allowed. All possible hybridizations between the mRNA and 16S rRNA are considered to find the highest affinity 16S rRNA binding site. The binding site minimizes the sum of the hybridization free energy ΔG_mRNA:rRNA and the penalty for nonoptimal spacing, ΔG_spacing. Thus, the algorithm can identify the 16S rRNA binding site regardless of its similarity to the consensus Shine-Dalgarno sequence.

• ΔG_start is the energy released when the start codon hybridizes to the initiating tRNA anticodon loop (3'-UAC-5').
• ΔG_spacing is the free energy penalty caused by a nonoptimal physical distance between the 16S rRNA binding site and the start codon (ΔG_spacing>0). When this distance is increased or decreased from an optimum of 5 nt (or ~17A), the 30S complex becomes distorted, resulting in a decreased translation initiation rate.
• Δ_GmRNA is the work required to unfold the mRNA sub-sequence when it folds to its most stable secondary structure, called the minimum free energy structure (ΔG_mRNA<0).
• ΔG_standby is the work required to unfold any secondary structures sequestering the standby site (ΔG_standby<0) after the 30S complex assembly. We define the standby site as the four nucleotides upstream of the 16S rRNA binding site, which is its location in a previously studied mRNA.

To calculate ΔG_mRNA:rRNA, ΔG_start, ΔG_mRNA and ΔG_standby, we use the NUPACK suite of algorithms with the Mfold 3.0 RNA energy parameters. These free energy calculations do not have any additional fitting or training parameters and explicitly depend on the mRNA sequence. In addition, the free energy terms are not orthogonal; changing a single nucleotide can potentially affect multiple energy terms. The relationship between the spacing and the ΔG_spacing was empirically determined by measuring the protein expression level driven by synthetic RBSs of varying spacing and fitting a quantitative model to this data.

Orthogonality Verification Experiment

Since orthogonal RBS is safe, why don’t we change all the original 16s into orthogonal 16s? The answer is no. that is because if we change all the base 16s, the other housekeeping genes will stop expressing. This will produce orthogonal toxicity, leading to bacterial death. So we are bound to face competition between base and orthogonal 16s. Then we design the following experiment to research this problem. We designed three operon to verify the orthogonality of our system. First, our first experiment is based on an assumption that the fluorescent light intensity can represent the amount of the expression of fluorescent protein. The relevant literature indicates that the with a fluorescent light intensity representative of the amount of the expression of fluorescent protein, the relevant literature indicates that the assumption can be right if the experimental precision is not sensitive.

We constructed two sets of plasmid co-transformed into E. coli to achieve the purpose. One set is induced by the promoter then transcripts the O-key's vector, which is equivalent to the key. The other set is O-RBS/RFP+RBS/GFP, it is constructed to compare the orthogonality of between the O-RBS and N-RBS by GFP and RFP.

From this figure, we can see that there are four competition relationship in the orthogonal cell system, the ideal state is the 1th and 2th path exists while the 3th and 4th path weaken. That means our system has good orthogonality. We did multiple sets of pre-experiments of different O-16s then decided to use this set.

Modeling

Future

Previous experiments and modeling has described that the orthogonality of our expression system is very tight, but we are still not satisfied with the current state, we design and do the following experiment. The following experiment includes:

1. We are using λRed technology to integrate the O-16s biobrick into the genome for constructing the orthogonal cells, so as to solve the revertants as well as stability problems caused by plasmid instability.
2. We are trying to build other groups of different orthogonal (O-16s-RBS) system, so as to achieve the different orthogonality switch effect, and attempt to make them corporate.
3. We also consult with some biological gene enterprises to make our results put into production in the life full of modern technology, such as genetic pollution control, gene encryption and metabolic regulation, etc.